APA (7th ed.) Citation

Konstantinopoulos, P. A., Costa, A. A. B. A. d., Gulhan, D., Lee, E. K., Cheng, S., Hendrickson, A. E. W., . . . Shapiro, G. I. (2021). A Replication stress biomarker is associated with response to gemcitabine versus combined gemcitabine and ATR inhibitor therapy in ovarian cancer. Nature Portfolio.

Chicago Style (17th ed.) Citation

Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.

MLA (8th ed.) Citation

Konstantinopoulos, Panagiotis A., et al. A Replication Stress Biomarker Is Associated with Response to Gemcitabine Versus Combined Gemcitabine and ATR Inhibitor Therapy in Ovarian Cancer. Nature Portfolio, 2021.